Ideally, anti-cancer treatments should specifically ... Building on these advances, antibody drug conjugate (ADC) therapy has emerged with worldwide marketing approvals for the indications of ...

A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...

Anti-idiotype antibodies are commonly employed in therapeutic drug development, such as immunogenicity evaluations and PK/PD studies. Sino Biological offers a comprehensive spectrum of bespoke ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

Under the terms of the Exclusive License, Radiance will pay CSPC an upfront payment of $15 million, and up to $150 million in potential development and regulatory milestone payments and over $1 ...

The researchers found that when the anti-cancer antibody binds to P-cadherin, it locks it into the X-dimer form. The stable X-form then triggers a chemical signal that causes that patch of membrane to ...

JSKN003 is an anti-HER2 biparatopic ADC, which is developed inhouse with Alphamab's proprietary Glycan-specific conjugation platform. Compared with its ADC counterparts, JSKN003 demonstrated better ...

Holdings announced its plans to advance the development of its proprietary Antibody Drug Conjugate (ADC) platform ...

25 (Xinhua) -- A Chinese research team has isolated an antibody from alpacas that can effectively inhibit HIV, providing a promising avenue for the development of new anti-AIDS drugs. The findings ...